This course is part of PrimaryCareNOW: Live on July 23, 2025.
Generic Placeholder Website Image

Activity content starts in:

Industry Webcast

The Evidence on Obesity & CV Risk: Clinical Trials Meet Real-WorldIndustry Webcast Sponsored by Novo Nordisk, Inc.; Not for CME/CE Credit

Understand that there is a need for obesity management that addresses the relationship between cardiovascular (CV) risk and obesity in appropriate adult patients with established CV disease. Analyze the efficacy and safety data from multiple randomized, controlled trials and explore complementary real-world evidence from routine clinical practice.

Register

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 7/23/2025

Expiration Date: 7/23/2025

Topics

Faculty

Faculty

Supporters and Partners

Industry Sponsor

Novo Nordisk

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The Evidence on Obesity & CV Risk: Clinical Trials Meet Real-World

Register